GR1001511B - Steroid formulations. - Google Patents

Steroid formulations.

Info

Publication number
GR1001511B
GR1001511B GR920100064A GR920100064A GR1001511B GR 1001511 B GR1001511 B GR 1001511B GR 920100064 A GR920100064 A GR 920100064A GR 920100064 A GR920100064 A GR 920100064A GR 1001511 B GR1001511 B GR 1001511B
Authority
GR
Greece
Prior art keywords
steroid formulations
role
steroid
formulations
tipredane
Prior art date
Application number
GR920100064A
Other languages
Greek (el)
Inventor
Joy Elaine Dr Saunders
Original Assignee
Fisons Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ag filed Critical Fisons Ag
Publication of GR1001511B publication Critical patent/GR1001511B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Abstract

Μια υδατική σύν?εσις εναιωρήματος η οποία περιέχει, ως δραστικόν συστατικόν, τιπρεδάνη. Η σύν?εσις είναι χρήσιμος δια την ?εραπευτικήν αγωγήν καταστάσεων της ρινός εις τις οποίες αλλεργικές ή ανοσοποιητικές αντιδράσεις παίζουν ένα σημαντικό ρόλο (ρόλο συμβολής). ωAn aqueous suspension composition containing, as active ingredient, tipredane. The composition is useful for the treatment of nasal conditions in which allergic or immune reactions play an important role (contributing role). ω

GR920100064A 1991-02-23 1992-02-18 Steroid formulations. GR1001511B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103824A GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation

Publications (1)

Publication Number Publication Date
GR1001511B true GR1001511B (en) 1994-02-28

Family

ID=10690478

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920100064A GR1001511B (en) 1991-02-23 1992-02-18 Steroid formulations.

Country Status (13)

Country Link
CN (1) CN1065010A (en)
AU (1) AU1247192A (en)
BE (1) BE1004177A4 (en)
FR (1) FR2673104A1 (en)
GB (1) GB9103824D0 (en)
GR (1) GR1001511B (en)
IE (1) IE920516A1 (en)
IL (1) IL101010A0 (en)
IT (1) IT1254627B (en)
MX (1) MX9200748A (en)
PT (1) PT100150A (en)
WO (1) WO1992014473A1 (en)
ZA (1) ZA921247B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (en) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc Aqueous pharmacological composition
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
AR026073A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
AR026072A1 (en) * 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION
DE10064950A1 (en) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropic nasal spray
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
EP2057982A1 (en) * 2007-11-09 2009-05-13 Archimedes Development Limited Intranasal compositions
WO2013049539A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. A method of blocking or trapping allergens
US20210220378A1 (en) * 2017-10-11 2021-07-22 Lifescience As N-acetylneuraminic acid compositions and methods of use
WO2020165578A1 (en) * 2019-02-11 2020-08-20 Reckitt Benckiser Health Limited Novel composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073026A1 (en) * 1981-08-20 1983-03-02 E.R. Squibb & Sons, Inc. 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions
EP0246652A2 (en) * 1986-05-22 1987-11-25 Syntex Pharmaceuticals International Limited Aqueous steroid formulations for nasal administration
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
WO1991011173A1 (en) * 1990-02-02 1991-08-08 Fisons Plc Propellant compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073026A1 (en) * 1981-08-20 1983-03-02 E.R. Squibb & Sons, Inc. 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions
EP0246652A2 (en) * 1986-05-22 1987-11-25 Syntex Pharmaceuticals International Limited Aqueous steroid formulations for nasal administration
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
WO1991011173A1 (en) * 1990-02-02 1991-08-08 Fisons Plc Propellant compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *

Also Published As

Publication number Publication date
FR2673104A1 (en) 1992-08-28
CN1065010A (en) 1992-10-07
WO1992014473A1 (en) 1992-09-03
ITMI920393A1 (en) 1993-08-21
IL101010A0 (en) 1992-11-15
PT100150A (en) 1993-05-31
IE920516A1 (en) 1992-08-26
BE1004177A4 (en) 1992-10-06
MX9200748A (en) 1992-10-01
ZA921247B (en) 1992-10-28
GB9103824D0 (en) 1991-04-10
ITMI920393A0 (en) 1992-02-21
AU1247192A (en) 1992-09-15
IT1254627B (en) 1995-09-28

Similar Documents

Publication Publication Date Title
FI862011A (en) THERAPEUTIC NUCLEOSIDER.
ATE73331T1 (en) USE OF TETRAHYDROBIOPTERINS TO MANUFACTURE A MEDICATION FOR THE TREATMENT OF CHILDREN'S AUTISM.
SE7903186L (en) CEREBRAL EFFICIENT
SE8804629A (en)
NO970051L (en) Aqueous risperidone formulations
NO163776C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOQUINOXALINES.
GR1001511B (en) Steroid formulations.
YU47116B (en) PROCEDURE FOR OBTAINING NEW N-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES
BR9709845B1 (en) aqueous insulin preparation, parenteral pharmaceutical formulation, and process for enhancing the chemical stability of an insulin preparation.
BR0015416A (en) Compositions containing tetraenoic hydroxyieic acid derivatives and methods of use in the treatment of dry eye disorders
AU7533091A (en) N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
ES2062610T3 (en) DIARILIC ANTI-ATEROSCLEROTIC COMPOUND.
DE3583916D1 (en) AQUEOUS MEDICINE FORMULATIONS OF PIROXICAMMONOHYDRATE.
ES2108129T3 (en) NEW DERIVATIVES OF PIRAZINE, ITS PREPARATION AND USE.
SE8404065D0 (en) NOVEL BIOLOGICALLY ACTIVE COMPOUNDS
GR1001597B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
SE8600658D0 (en) NOVEL COMPOSITION OF MATTER
IT1240683B (en) PHARMACEUTICAL COMPOSITION CONTAINING EGF
ATE204752T1 (en) THERAPEUTIC USES OF 2',5'-OLIGOADENYLATE DERIVATIVES
ATE104554T1 (en) TOPICAL PREPARATIONS.
DE3778642D1 (en) THERAPEUTIC FOR TREATMENT OF STOMACH.
DE59101818D1 (en) Pharmaceutical preparation containing stigmasta-4-en-3-one and their use.
PT1232173E (en) FUSIDIC ACID DERIVATIVES
NO167801C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,2'-BI-1H IMIDAZOLD DERIVATIVES.
IT1224404B (en) ACTIVE COMPOUNDS ON THE CARDIOVASCULAR SYSTEM